Shenzhen Glory Medical Co.,Ltd. (002551.SZ)
CNY 3.58
(-0.83%)
CNY 3.58
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 17.63 Million | 96.45 Million | 242.59 Million | 497.53 Million | 139.87 Million | 42.21 Million |
| Net Income | -160.82 Million | -327.9 Million | 88.01 Million | 369.94 Million | 76.42 Million | 134.71 Million |
| Depreciation & Amortization | 95.88 Million | 124.99 Million | 76.67 Million | 55.1 Million | 39.58 Million | 32.02 Million |
| Deferred income taxes | 33.13 Million | -44.35 Million | -1.24 Million | -1.13 Million | -25.06 Million | -14.88 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -32.42 Million | -90.36 Million | 57.93 Million | 30.59 Million | -57.86 Million | -226.73 Million |
| Other non-cash items | 114.99 Million | 389.72 Million | 19.96 Million | 41.88 Million | 81.72 Million | 102.21 Million |
| Investing Cash Flow | 73.86 Million | -176.84 Million | -563.38 Million | -148.59 Million | -530.23 Million | -228.26 Million |
| Investments in PPE | -42.07 Million | -57.3 Million | -429.97 Million | -254.2 Million | -254.61 Million | -357.27 Million |
| Acquisitions | 1.08 Million | 1.5 Million | 485.29 Thousand | -67.12 Million | 255.04 Million | 447.34 Million |
| Investment purchases | -1.09 Billion | -865.39 Million | -1.22 Billion | -295.15 Million | -817.02 Million | -199 Million |
| Sales/Maturities of investments | 1.21 Billion | 732.62 Million | 1.08 Billion | 473.26 Million | 540.96 Million | 237.93 Million |
| Other Investing Activities | 381.2 Thousand | 11.72 Million | -99.99 Thousand | -5.37 Million | -254.61 Million | -357.27 Million |
| Financing Cash Flow | -78.6 Million | -191.09 Million | 8.31 Million | 84.91 Million | 651.96 Million | -111.42 Million |
| Debt repayment | -41.46 Million | -88.81 Million | -248.39 Million | -204.24 Million | -358.5 Million | -814.06 Million |
| Dividends payments | -58.84 Million | -163.95 Million | -30.28 Million | -49.77 Million | -61.48 Million | -84.5 Million |
| Common Stock Repurchased | - | - | - | - | - | -242.67 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 21.69 Million | 61.67 Million | 287 Million | 338.93 Million | 1.08 Billion | 787.14 Million |
| Accounts receivables | 29.16 Million | 156.27 Million | 49.62 Million | 116.21 Million | 183.36 Million | -46.45 Million |
| Accounts payables | -103.46 Million | -146.37 Million | 48.14 Million | -43.47 Million | -167.02 Million | -271.68 Million |
| Inventory | 8.73 Million | -55.91 Million | -38.58 Million | -41 Million | -49.13 Million | 106.28 Million |
| Other working capital | -41.15 Million | -44.35 Million | -1.24 Million | -1.13 Million | -25.06 Million | -333.02 Million |
| Cash at beginning of period | 387.2 Million | 652.64 Million | 960.37 Million | 546.8 Million | 283.21 Million | 580.78 Million |
| Cash at end of period | 407.24 Million | 387.2 Million | 652.64 Million | 960.37 Million | 546.8 Million | 283.21 Million |
| Capital Expenditure | -42.07 Million | -57.3 Million | -429.97 Million | -254.2 Million | -254.61 Million | -357.27 Million |
| Effect of forex changes on cash | 7.14 Million | 6.05 Million | 4.73 Million | -20.28 Million | 1.98 Million | -86.04 Thousand |
| Net cash flow / Change in cash | 20.04 Million | -265.43 Million | -307.73 Million | 413.56 Million | 263.59 Million | -297.56 Million |
| Free Cash Flow | -24.44 Million | 39.15 Million | -187.37 Million | 243.32 Million | -114.73 Million | -315.05 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 700.94 Thousand | 143.15 Thousand | 13.88 Million | -162.4 Million | -160.82 Million | 1.96 Million |
| Depreciation & Amortization | - | 56.81 Million | 56.81 Million | 27.41 Million | 95.88 Million | -12.29 Million |
| Deferred income taxes | - | - | - | - | 33.13 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 3.14 Million | - | 37.89 Million | -32.42 Million | 23.03 Million |
| Other non-cash items | 108.55 Million | 91.28 Million | 42.93 Million | 93.69 Million | 114.99 Million | 47.76 Million |
| Investing Cash Flow | -156.31 Million | -97.75 Million | 73.8 Million | -43.86 Million | 73.86 Million | 54.12 Million |
| Investments in PPE | -13.7 Million | -6.34 Million | -5.98 Million | -21.82 Million | -42.07 Million | -5.09 Million |
| Acquisitions | 118.33 Thousand | - | - | 231.56 Thousand | 1.08 Million | 1 Million |
| Investment purchases | -465.95 Million | -378 Million | -249.21 Million | -325.88 Million | -1.09 Billion | -230 Million |
| Sales/Maturities of investments | 323.23 Million | 286.59 Million | 329 Million | 303.43 Million | 1.21 Billion | 288.21 Million |
| Other Investing Activities | 118.33 Thousand | -90.56 Million | 81.61 Million | 366.2 Thousand | 381.2 Thousand | 6500.06 |
| Financing Cash Flow | -31.25 Million | -49.44 Million | 25.38 Million | 11.63 Million | -78.6 Million | -60.3 Million |
| Debt repayment | -35.39 Million | -44.44 Million | -890 Thousand | -31.05 Million | -41.46 Million | -41.98 Million |
| Dividends payments | -1.73 Million | -1.64 Million | -4.48 Million | -51.39 Million | -58.84 Million | -1.35 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.87 Million | -32.4 Million | 26.27 Million | 31.96 Million | 21.69 Million | -16.96 Million |
| Accounts receivables | - | -18.25 Million | - | 29.16 Million | 29.16 Million | 27.74 Million |
| Accounts payables | - | - | - | - | -103.46 Million | - |
| Inventory | - | 21.39 Million | - | 8.73 Million | 8.73 Million | -4.71 Million |
| Other working capital | - | - | - | - | -41.15 Million | - |
| Cash at beginning of period | 452.23 Million | 616.75 Million | 490.31 Million | 533.37 Million | 387.2 Million | 479.05 Million |
| Cash at end of period | 373.07 Million | 505.66 Million | 616.75 Million | 407.24 Million | 407.24 Million | 533.37 Million |
| Capital Expenditure | -13.7 Million | -6.34 Million | -5.98 Million | -21.82 Million | -42.07 Million | -5.09 Million |
| Effect of forex changes on cash | 1.05 Million | 950.4 Thousand | 611.27 Thousand | -3.39 Million | 7.14 Million | 42.16 Thousand |
| Net cash flow / Change in cash | -79.16 Million | -111.08 Million | 126.43 Million | -126.12 Million | 20.04 Million | 54.32 Million |
| Free Cash Flow | 95.54 Million | 28.27 Million | 50.83 Million | -112.33 Million | -24.44 Million | 55.36 Million |
WELSPLSOL
SIKOZY
FZRO
LMLLF
BTRCF
WCUI